Archív dokumentov Europa Uomo

• M19:Europa Uomo (Louis Denis - Antwerpy, Monaco 06)
• M20: Overdetection of prostate cancer (Chris H.Bangma, ESMO, 2007, Brusel)
• M21: EU European Prostate Pasport - Recommendations from Berlin, 2007)
• M22: Prostate Cancer Bridging the GAP in Europe (ESMO Patient Coalition Forum, Louis Denis, 2007, Brusel)
• M23: What´s New in Prostate Cancer - (EAU, Berlin, J.Yee, 2007)
• M24: The Endothelin Axis: Oncogenic Mechanism - (EAU - Europa Uomo, A.von Eschenbach, 2007)
• M31: EU-The European Prostate Cancer Coalition (J.Moreau & L.Denis, OECI Workshop, Avignon, 14.3.05)
• M32: Management of Senior Adults with Prostate Ca (L.Denis, Europa Uomo, Milan, 27.3.08)
• M33: Recent Advances in Prostate Cancer.Part 1. (Per-Anders Abrahamsson, Sweden, Europa Uomo Italia Onlus, Milan, 29.3.08)
• M34: Recent Advances in Prostate Cancer.Part 2. (Per-Anders Abrahamsson, Sweden, Europa Uomo Italia Onlus, Milan, 29.3.08)
• M35: Recent Advances in Prostate Cancer.Part 3. (Per-Anders Abrahamsson, Sweden, Europa Uomo Italia Onlus, Milan, 29.3.08)
• M36: Recent Advances in Prostate Cancer.Part 4. (Per-Anders Abrahamsson, Sweden, Europa Uomo Italia Onlus, Milan, 29.3.08)
• M37: PROCABIO - the treatment of ca prostate by biomarkers (C.Bangma, EAU, Brussels, 28.3.08)
• M38: Improving Patient Participation and Information on Clinical Trials(ECPC, J Giessler, Brussel, 8.4.2008)
• M39: Cancer Patients - Partners for Change (ECPC, H. Sunseth, Brussel, 8.4.2008)
• M41: What a patient expects from his pharmacist (L.Denis, Luxembourgh, 26.9.2008)
• M43: WWPCC Geneva (Hudson 28_8_2008)
• M44: ESMO Stockholm Sept 08(Van Poppel)
• M51: Active surveillance and the PRIAS protocol, J.Roobol, Krakow, 9.2.2009
• M52: Controversies in Prostate Diseases, L.Denis, Krakow, 6.2.09
• M53: Multiprofessional disciplinary approach (Valdagni, GA EU, Stockholm, 19.3.09)
• M54: Advnces in the managementsof BPH/LUTS(H.Chaple, Sheffield Univ., GA EU, Stockholm, 19.3.09)
• M55: Screening, early diagnosis, treatment, active surveillance for prostate cancer (Ch.C.Bangma, Rotterdam, 2009)
• M57: The Future of Prostate Cancer: Urologistś and European Perspectives (PA Abrahamson,EAU Stockholm 2009)
• M58: New Developments in the Treatment of HRPC (B.Tomba, EAU Stockholm 2009)
• M59: Adjuvant or Salvage Radiotherapy after Radical Prostatectomy(M.Wirth,TU Dresden, 2009)
• M64: GA EU 09 - Report of the Secretary (L.Denis, Stockholm)
• M65: GA EU 09 - Prostate Cancer Research in Europe (G.Feick, Stockholm)
• M66: GA EU 09 - A Guide to Starting a PCSHS Group (M.Lockett, Stockholm)
• Prostate Cancer Final report for HCP
• Why HRQoL is important to Patients (nov 26 Brussels
• M71- Europa Uomo 2011
• Becoming a qualified Advocate
• PARKER (EAU 2012 EUomo)
• ROOBOL (Paris 120225)
• VALDAGNI (EUomo EAU Paris ESO Pca Programme 2012)
• BELLARDITA (Paris 120236)
• M79-EPAD 2012
• M80-Europa Uomo 2011
• M81-UOMO LUTS BPH final Chapple
• M82-Message 33 PCa Incidence Mortality
• M83-Portal 4 - Riskman 2012 (K. Mastris)
• M84-Portal 4 - Report of the StratComm EU 2012 (G.Feick)
• M85-Portal 5 - Good PCa Care (SFPCA C. Waller)
• M86-Portal 6 - EUomo Forum (EPCC)
• Improving prostate cancer care across Europe
• A BRIEF COMPARISON OF NATIONAL CANCER HEALTH SERVICES
• The many faces of advanced stage prostate cancer
• DUNCAN Newsletter
• HUDSON White Paper timeline
• Action Program EUomo 2014
• Minutes Members meeting GenAssembly 2014
• EAPM Annual Conference Report Integrating Personalised Medicine into the EU Health Strategy
• Overview latest treatments CRPC full article
• Understanding the Complexity of Survivorship in Modern Oncology
• 360 Degree Prospectives on Prostate Cancer - Vienna